Anthrax differential diagnosis

Revision as of 20:03, 20 July 2014 by Joao Silva (talk | contribs)
Jump to navigation Jump to search

Anthrax Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Anthrax from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anthrax differential diagnosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Anthrax differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anthrax differential diagnosis

CDC on Anthrax differential diagnosis

Anthrax differential diagnosis in the news

Blogs on Anthrax differential diagnosis

Directions to Hospitals Treating Anthrax

Risk calculators and risk factors for Anthrax differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The differential diagnosis of anthrax includes a wide range of infectious and non-infectious conditions. Depending on the mode of anthrax exposure in the patient (cutaneous, ingestion, inhalation or injection), there will be different forms of the disease.[1] A history of exposure to contaminated animal materials, occupational exposure, and living in an endemic area, are crucial when considering the diagnosis of anthrax. Additional tests to isolate Bacillus anthracis are required to differentiate anthrax from other diagnoses, thereby confirming the correct etiologic agent.

Differential Diagnosis

Cutaneous Anthrax

  • A history of exposure to contaminated animal materials, occupational exposure, and living in an endemic area is crucial when considering a diagnosis of anthrax. A painless, pruritic papule, surrounding vesicles and edema, usually on an exposed region of the body should raise a concern of cutaneous anthrax, which is confirmed by the demonstration of Gram-positive encapsulated bacilli from the lesion and/or positive culture for Bacillus anthracis from the lesion and/or positive specialized tests.
  • The differential diagnosis of the anthrax eschar includes a wide range of infectious and non-infectious conditions including:[1]
  • Generally these other diseases and conditions lack the characteristic edema of anthrax. The absence of pus, the lack of pain, and the patient’s occupation may provide further diagnostic clues. The outbreak of Rift Valley fever, initially thought to be anthrax in livestock, also affected numerous humans.

Ingestional Anthrax (Oropharyngeal and Gastrointestinal Anthrax)

Oropharyngeal Anthrax

Gastrointestinal Anthrax

Inhalational Anthrax (Pulmonary, Mediastinal, and Respiratory Anthrax)

Anthrax Meningitis

Anthrax Sepsis

  • Sepsis due to other bacteria should be considered.
  • The definitive diagnosis of anthrax is made by the isolation of Bacillus anthracis from the primary lesion and from blood cultures or by detection of the toxin or DNA (deoxyribonucleic acid) of B. anthracis in these specimens.[1]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Turnbull, Peter (2008). Anthrax in humans and animals. Geneva, Switzerland: World Health Organization. ISBN 9789241547536.